Værløse, Denmark

Lene Teuber

USPTO Granted Patents = 44 

 

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 178(Granted Patents)


Location History:

  • Anemonevej, DK (1996)
  • Varlose, DK (1996)
  • Glostrup, DK (2001)
  • Vaerløse, DK (2002)
  • Vaerloese, DK (2003 - 2004)
  • Vaerlose, DK (1999 - 2008)
  • Værløe, DK (2008)
  • Ballerup, DK (2010)
  • Væløse, DK (2010 - 2011)
  • Værlose, DK (2011)
  • Værlese, DK (2011)
  • Værløse, DK (2001 - 2020)
  • Copenhagen, DK (2022)

Company Filing History:


Years Active: 1996-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclyl-Substituted Derivatives
Potassium Channel Modulators
Bromodomains
Guanidine Derivatives
2-Aminio-Pyridine Derivatives
Imidazole Derivatives
Benzimidazole Derivatives
Ion Channel Modulating Agents
KCNQ Channel Modulating Compounds
GABA-A Receptor Modulators
Calcium-Activated Potassium Channels
44 patents (USPTO):Explore Patents

Title: The Innovative Mind of Lene Teuber

Introduction: Lene Teuber, an accomplished inventor based in Værløse, Denmark, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 44 patents, her work primarily focuses on developing new therapeutic compounds that address various medical challenges.

Latest Patents: Among her latest innovations are several noteworthy patents. One patent pertains to optionally fused heterocyclyl-substituted derivatives of pyrimidine, which are essential in the treatment of inflammatory, metabolic, oncologic, and autoimmune diseases. This invention discloses compounds that exhibit activity towards nuclear receptors, offering promising pharmaceutical compositions for therapeutic use. Another significant patent involves compounds that are active towards bromodomains, also revealing pharmaceutical compositions and therapeutic applications for these inventive compounds.

Career Highlights: Throughout her career, Lene has been associated with several reputable companies, including Neurosearch A/S and Meiji Seika Kaisha, Ltd. Her expertise in drug development and her innovative spirit have allowed her to pave the way in the pharmaceutical industry.

Collaborations: In her journey, Lene has collaborated with distinguished colleagues, notably Palle Christophersen and Dan Peters. These partnerships have fostered a productive environment for exchanging ideas and advancing research in the pharmaceutical domain.

Conclusion: Lene Teuber exemplifies the drive and creativity that fuel innovative advancements in medicine. With her extensive patent portfolio and strategic collaborations, she continues to contribute to the evolution of therapies that can significantly alter patient care and treatment methodologies. Her work is a testament to the impactful role of inventors in the quest for health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…